Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 21, 2018
Pharmacy Choice - News - U.S. Pharmaceutical Industry - May 21, 2018

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

5/21/18 - "Covalent Conjugates of Bet Inhibitors and Alpha Amino Acid Esters" in Patent Application Approval Process (USPTO 20180117165)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors BROWN, John Alexander; JONES, Katherine Louise; PRINJHA, Rabinder Kumar; WITHERINGTON, Jason, filed on March 17, 2016, was made available online on May 10, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents
5/21/18 - "Method of Preparing Glucagon-Like Peptide-2 (Glp-2) Analog" in Patent Application Approval Process (USPTO 20180118800)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors CHEN, Shih-Lin; HSIUNG, Ting-Yu, filed on January 17, 2017, was made available online on May 10, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a compan
5/21/18 - "Pharmaceutical Composition for Oral Administration" in Patent Application Approval Process (USPTO 20180116965)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors SUDA, Yumiko; SAKAI, Toshiro; KOJIMA, Ryo; OYAMA, Dal; NISHIMURA, Koji; NAIKI, Kumi, filed on April 27, 2016, was made available online on May 10, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This pa
5/21/18 - "Radiolabeled Active Targeting Pharmaceutical Composition and the Use Thereof" in Patent Application Approval Process (USPTO 20180117188)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors WANG, Hsin-Ell; HSIA, Chien-Chung; WENG, Mao-Chi; LIN, Kun-Liang; KAO, Hao-Wen; CHEN, Chao-Cheng; CHI, Kwan-Hwa; TIEN, Der-Chi; LIN, Wuu-Jyh, filed on September 14, 2017, was made available online on May 10, 2018, according to news reporting origina
5/21/18 - Abbott Laboratories Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (May. 8, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Abbott Laboratories was posted on May 8, 2018. The SEC file number is 0001179110-18-006429.. A U.S. Securities and Exchange Commission filing is a fo
5/21/18 - Acerus to Report First Quarter 2018 Financial Results and Host Investor Call
By a News Reporter-Staff News Editor at Pharma Business Week Acerus Pharmaceuticals Corporation will announce its first quarter 2018 financial and operating results on Tuesday May 15, 2018 before market opens. The Company commercializes its products via its own salesforce in Canada, and through a global network of licensed distributors in the U.S
5/21/18 - Adamas Pharmaceuticals Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (May. 3, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Adamas Pharmaceuticals Inc. was posted on May 3, 2018. The SEC file number is 0001628280-18-005826.. A U.S. Securities and Exchange Commission filing
5/21/18 - Adamas Pharmaceuticals Inc. Files SEC Form 8-K, Current Report: (May. 3, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Adamas Pharmaceuticals Inc. was posted on May 3, 2018. The SEC file number is 0001628280-18-005830.. A U.S. Securities and Exchange Commission filing
5/21/18 - Aerie Pharmaceuticals Inc. Files SEC Form 8-K, Current Report: (May. 8, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Aerie Pharmaceuticals Inc. was posted on May 8, 2018. The SEC file number is 0001564590-18-011798.. A U.S. Securities and Exchange Commission filing
5/21/18 - Alimera Sciences Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (May. 7, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Alimera Sciences Inc. was posted on May 7, 2018. The SEC file number is 0001267602-18-000064.. A U.S. Securities and Exchange Commission filing is a
5/21/18 - Alimera Sciences Inc. Files SEC Form 8-K, Current Report: (May. 3, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Alimera Sciences Inc. was posted on May 3, 2018. The SEC file number is 0001267602-18-000062.. A U.S. Securities and Exchange Commission filing is a
5/21/18 - Allergan Plc Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (May. 3, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Allergan Plc was posted on May 3, 2018. The SEC file number is 0001564590-18-010702.. A U.S. Securities and Exchange Commission filing is a formal do
5/21/18 - Allergan Plc Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (May. 3, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Allergan Plc was posted on May 3, 2018. The SEC file number is 0001179110-18-006112.. A U.S. Securities and Exchange Commission filing is a formal do
5/21/18 - Allergan Plc Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (May. 4, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Allergan Plc was posted on May 4, 2018. The SEC file number is 0001179110-18-006352.. A U.S. Securities and Exchange Commission filing is a formal do
5/21/18 - Allergan Plc Files SEC Form 8-K, Current Report: (May. 3, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Allergan Plc was posted on May 3, 2018. The SEC file number is 0001193125-18-149657.. A U.S. Securities and Exchange Commission filing is a formal do
5/21/18 - Amag Pharmaceuticals Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (May. 4, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Amag Pharmaceuticals Inc. was posted on May 4, 2018. The SEC file number is 0000792977-18-000023.. A U.S. Securities and Exchange Commission filing i
5/21/18 - Amag Pharmaceuticals Inc. Files SEC Form 8-K, Current Report: (May. 3, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Amag Pharmaceuticals Inc. was posted on May 3, 2018. The SEC file number is 0000792977-18-000020.. A U.S. Securities and Exchange Commission filing i
5/21/18 - Amneal Pharmaceuticals, Inc. Files SEC Form 3, Initial Statement of Beneficial Ownership of Securities: (May. 8, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Amneal Pharmaceuticals, Inc. was posted on May 8, 2018. The SEC file number is 0000899243-18-011936.. A U.S. Securities and Exchange Commission filin
5/21/18 - Amneal Pharmaceuticals, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (May. 8, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Amneal Pharmaceuticals, Inc. was posted on May 8, 2018. The SEC file number is 0000899243-18-011952.. A U.S. Securities and Exchange Commission filin
5/21/18 - Amneal Pharmaceuticals, Inc. Files SEC Form 8-A12B, Registration of Securities [Section 12(B)]: (May. 4, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Amneal Pharmaceuticals, Inc. was posted on May 4, 2018. The SEC file number is 0001193125-18-152487.. A U.S. Securities and Exchange Commission filin
5/21/18 - Amneal Pharmaceuticals, Inc. Files SEC Form 8-K, Current Report: (May. 7, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Amneal Pharmaceuticals, Inc. was posted on May 7, 2018. The SEC file number is 0001193125-18-153514.. A U.S. Securities and Exchange Commission filin
5/21/18 - Amneal Pharmaceuticals, Inc. Files SEC Form CERT, (May. 4, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Amneal Pharmaceuticals, Inc. was posted on May 4, 2018. The SEC file number is 0000876661-18-000480.. A U.S. Securities and Exchange Commission filin
5/21/18 - Amneal Pharmaceuticals, Inc. Files SEC Form RW, Registration Withdrawal Request: (May. 7, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Amneal Pharmaceuticals, Inc. was posted on May 7, 2018. The SEC file number is 0001193125-18-153738.. A U.S. Securities and Exchange Commission filin
5/21/18 - Amneal Pharmaceuticals, Inc. Files SEC Form S-1, General Form For Registration of Securities Under The Securities Act of 1933: (May. 7, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Amneal Pharmaceuticals, Inc. was posted on May 7, 2018. The SEC file number is 0001193125-18-153798.. A U.S. Securities and Exchange Commission filin
5/21/18 - Amneal Pharmaceuticals, Inc. Files SEC Form S-8, Securities To Be Offered To Employees in Employee Benefit Plans: (May. 7, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Amneal Pharmaceuticals, Inc. was posted on May 7, 2018. The SEC file number is 0001193125-18-153676.. A U.S. Securities and Exchange Commission filin
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415